Literature DB >> 32999878

Resting Left Ventricular Dyssynchrony and Mechanical Reserve in Asymptomatic Normotensive Subjects with Early Type 2 Diabetes Mellitus.

Ragab A Mahfouz1, Elshaimaa A Seaoud1, Radwa A Elbelbesy1, Islam E Shehata1.   

Abstract

BACKGROUND: Most diabetic patients have silent ischemia and cardiac dysfunction that is usually observed in the late phase of the disease when it becomes clinically obvious. We hypothesized that left ventricular dyssynchrony (LVdys) (or dispersion) is an early marker of myocardial involvement in asymptomatic early type 2 diabetes mellitus (T2DM) patients. Therefore, we aimed to detect early markers of myocardial dysfunction in early T2DM using LVdys and left ventricular mechanical reserve (LVMR).
METHODS: We examined 91 consecutive subjects with early T2DM with speckle tracking imaging to evaluate LVdys and with dobutamine stress to evaluate LVMR (defined as left ventricular mechanical reserve global longitudinal strain [LVMRGLS] ≥2%). Our patients were divided into two groups according to LVdys: group 1 with LVdys (n = 49), and group 2 without LVdys (n = 42).
RESULTS: We found that 49 (54%) subjects in our cohort had resting LVdys (standard deviation of tissue synchronization of the 12 left ventricular segments [Ts-SD-12] ≥34.2 ms). GLS and strain rate were comparable at rest between patients with and without LVdys. On the other hand, LVMR was blunted in those with LVdys (p < 0.001). We found that HbA1c, high-sensitivity C-reactive protein, and left atrial volume index were inversely correlated with LVMR. Multivariate analysis showed that LVdys was the strongest predictor (p < 0.001) of blunted LVMR. Using receiver operating characteristic curve analysis, we found that a Ts-SD-12 ≥36.5 ms was the best cutoff value to predict blunted LVMR (area under the curve = 0.89, p < 0.001).
CONCLUSION: The LVdys (Ts-SD-12) cutoff ≥36.5 ms was the optimal value for prediction of impaired LVMR and might be an early marker of subclinical cardiac dysfunction and risk stratification of subjects with asymptomatic early T2DM with preserved left ventricular ejection fraction.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Contractile reserve; Coronary flow; Diabetes mellitus; Dyssynchrony; Mechanical reserve; Subclinical cardiomyopathy

Year:  2020        PMID: 32999878      PMCID: PMC7506294          DOI: 10.1159/000506712

Source DB:  PubMed          Journal:  Pulse (Basel)        ISSN: 2235-8668


  25 in total

1.  Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging.

Authors:  Jens-Uwe Voigt; Gianni Pedrizzetti; Peter Lysyansky; Tom H Marwick; Helen Houle; Rolf Baumann; Stefano Pedri; Yasuhiro Ito; Yasuhiko Abe; Stephen Metz; Joo Hyun Song; Jamie Hamilton; Partho P Sengupta; Theodore J Kolias; Jan d'Hooge; Gerard P Aurigemma; James D Thomas; Luigi Paolo Badano
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-12-18       Impact factor: 6.875

2.  Isovolumic acceleration at rest and during exercise in children normal values for the left ventricle and first noninvasive demonstration of exercise-induced force-frequency relationships.

Authors:  Susan Lucy Roche; Michael Vogel; Oli Pitkänen; Brian Grant; Cameron Slorach; Cheryl Fackoury; Derek Stephens; Jeffrey Smallhorn; Lee N Benson; Paul F Kantor; Andrew N Redington
Journal:  J Am Coll Cardiol       Date:  2011-03-01       Impact factor: 24.094

3.  Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy.

Authors:  Kursat Tigen; Tansu Karaahmet; Cevat Kirma; Cihan Dundar; Selcuk Pala; Iclal Isiklar; Cihan Cevik; Alev Kilicgedik; Yelda Basaran
Journal:  J Am Soc Echocardiogr       Date:  2010-02-10       Impact factor: 5.251

4.  Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial.

Authors:  Sandeep R Das; Mark H Drazner; Clyde W Yancy; Lynne W Stevenson; Bernard J Gersh; Daniel L Dries
Journal:  Am Heart J       Date:  2004-11       Impact factor: 4.749

5.  Determinants of subclinical diabetic heart disease.

Authors:  Z Y Fang; R Schull-Meade; M Downey; J Prins; T H Marwick
Journal:  Diabetologia       Date:  2005-01-08       Impact factor: 10.122

6.  Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study.

Authors:  Frans J Th Wackers; Lawrence H Young; Silvio E Inzucchi; Deborah A Chyun; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Steven D Wittlin; Gary V Heller; Neil Filipchuk; Samuel Engel; Robert E Ratner; Ami E Iskandrian
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

7.  Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation.

Authors:  Raymond J Clark; Patrick M McDonough; Eric Swanson; Susanne U Trost; Misa Suzuki; Minoru Fukuda; Wolfgang H Dillmann
Journal:  J Biol Chem       Date:  2003-08-26       Impact factor: 5.157

8.  Impaired left ventricular synchronicity in hypertensive patients with ventricular hypertrophy.

Authors:  Hong-wei Tan; Guo-ling Zheng; Li Li; Zhi-hao Wang; Hui-ping Gong; Yun Zhang; Ming Zhong; Wei Zhang
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844

9.  Prognostic value of left ventricular mechanical dyssynchrony indices in long-standing type II diabetes mellitus with normal perfusion and left ventricular systolic functions on SPECT-MPI.

Authors:  Dharmender Malik; Bhagwant Rai Mittal; Ashwani Sood; Madan Parmar; Komalpreet Kaur; Ajay Bahl
Journal:  J Nucl Cardiol       Date:  2018-09-12       Impact factor: 5.952

Review 10.  Echocardiographic assessment of left ventricular relaxation and cardiac filling pressures.

Authors:  Sherif F Nagueh
Journal:  Curr Heart Fail Rep       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.